In this context, previous reports have shown that knockout of IL-36R promotes DSS (2.5%)-induced colitis but alleviates DSS (1.5–2%)-induced colon fibrosis (Scheibe et al., 2017, 2019). Here, IL1RL2 is linked to colitis.